PHK
ADPT icon

Point72 Hong Kong’s Adaptive Biotechnologies ADPT Stock Holding History

Point72 Hong Kong’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-267
Closed -$11K – 1922
2021
Q2 		$11K Buy
+267
New +$10.4K ﹤0.01% 1723
2020
Q4 		– Sell
-10,232
Closed -$498K – 1680
2020
Q3 		$498K Buy
10,232
+5,895
+136% +$248K 0.05% 295
2020
Q2 		$210K Buy
+4,337
New +$158K 0.02% 504
2019
Q3 		– Sell
-4,474
Closed -$216K – 959
2019
Q2 		$216K Buy
+4,474
New +$198K 0.06% 302

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Point72 Hong Kong's ADPT Position: Q3 2021 in Review

Point72 Hong Kong sold out of Adaptive Biotechnologies (ADPT) in Q3 2021, closing a stake of 267 shares — an estimated $11K sold.

Point72 Hong Kong first reported a position in ADPT in Q2 2019 and held it in 4 quarters. The position peaked at $498K in Q3 2020. 219 funds tracked by Wall St. Rank hold ADPT as of Q3 2021.

  • Point72 Hong Kong reported no remaining Adaptive Biotechnologies position as of Q3 2021 after selling out during the quarter.
  • Point72 Hong Kong sold 267 Adaptive Biotechnologies shares in Q3 2021, an estimated $11K.
  • Point72 Hong Kong first reported a position in Adaptive Biotechnologies in Q2 2019 and held it in 4 quarters.
  • Point72 Hong Kong's Adaptive Biotechnologies position peaked at $498K in Q3 2020.
  • 219 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2021.

Based on Point72 Hong Kong's 13F filing for Q3 2021, filed 15 Nov 2021.